A previous report clarified that AKT-mediated EZH2-S21 phosphorylation represses EZH2 methyltransferase activity, leading to a decrease in the amount of H3K27me3 on EZH2 target genes in breast cancer cells [27]. The gene discussed is EZH2; the disease is breast cancer.